Blood Glucose Monitoring Devices Market Size & Growth Forecast 2027–2036, By Segments (Product, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Blood Glucose Monitoring Devices Market size stood at USD 16.8 billion in 2026 and is predicted to grow at a 8.36% CAGR from 2027 to 2036, attaining USD 37.5 billion by 2036. The industry revenue for 2027 is assessed at USD 17.98 billion.
Get more details on this report
Request Free Sample ReportBlood Glucose Monitoring Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 40.28% market share in 2026, supported by established diabetes management, broad device availability, strong reimbursement access, and consistent use of self-monitoring and continuous monitoring technologies.
- Asia Pacific is projected to grow at a 9.38% CAGR, driven by rising diabetes incidence, expanding healthcare access, broader device availability, and increasing adoption of technology-enabled glucose monitoring.
Segment Momentum
- Self-monitoring Devices held a 64.02% share in 2026 due to their established role in routine diabetes management, broad user familiarity, and suitability for regular point-in-time blood glucose testing.
- Home Care is growing fastest as diabetes management shifts toward convenient, routine monitoring outside hospitals, supporting long-term self-management and meeting increasing demand for decentralized care.
Market Expansion Drivers
- Rising diabetes prevalence and aging population increasing monitoring device demand.
- Advancements in continuous glucose monitoring and Bluetooth-enabled smart devices.
- Expansion of telehealth and remote patient monitoring improving chronic care adoption.
Leading Market Participants
- Major players in the blood glucose monitoring devices market include Abbott Laboratories (United States), DexCom, Inc. (United States), Medtronic plc (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), Senseonics Holdings, Inc. (United States), Insulet Corporation (United States), i-SENS, Inc. (South Korea), Sinocare Inc. (China), Ypsomed Holding AG (Switzerland), AgaMatrix, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 16.8 billion
- 2027 Estimated Market Size: USD 17.98 billion.
- Projected Market Size: USD 37.5 billion by 2036
- Growth Forecast: 8.36% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Self-monitoring Devices (Product) | Hospitals (End-use)
- Emerging Opportunity Segment: Continuous Blood Glucose Monitoring Devices (Product) | Home Care (End-use)
Market Growth Drivers and Industry Trends
Rising diabetes prevalence and aging population increasing monitoring device demand
The increasing burden of diabetes and the expanding older population are supporting the blood glucose monitoring devices market by creating a larger need for regular glucose assessment and chronic disease management. Individuals managing diabetes often require ongoing monitoring to understand glucose fluctuations and make informed decisions regarding diet, medication, and daily activities. Aging populations can also experience greater demand for healthcare monitoring because chronic conditions become more prevalent with advancing age. This demographic and disease-related demand is encouraging wider use of blood glucose meters and other monitoring technologies across home-based and clinical care settings.
Advancements in continuous glucose monitoring and Bluetooth-enabled smart devices
Technological innovation is reshaping the blood glucose monitoring devices market through the development of continuous glucose monitoring systems and connected devices that provide more convenient access to glucose information. Continuous monitoring can reduce reliance on intermittent measurements by enabling users to observe glucose patterns over time, while bluetooth connectivity allows compatible devices to transmit readings to smartphones and other digital platforms. These capabilities can support easier data tracking, personalized monitoring, and improved communication between users and healthcare professionals. Enhanced sensor performance, compact designs, and increasingly connected ecosystems are also making glucose monitoring more integrated with everyday health management.
Expansion of telehealth and remote patient monitoring improving chronic care adoption
The wider adoption of telehealth and remote patient monitoring is strengthening the blood glucose monitoring devices market by enabling healthcare providers to review patient-generated glucose information beyond conventional clinical visits. Connected monitoring devices can facilitate the transmission of relevant readings to digital health platforms, allowing healthcare professionals to identify changes in glucose patterns and support ongoing disease management. Remote monitoring is particularly useful for patients who require regular follow-up but may face barriers to frequent in-person consultations. Integration with digital care pathways also encourages more continuous engagement with chronic condition management and supports individualized monitoring strategies.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising diabetes prevalence and aging population increasing monitoring device demand | 2.00% | Low | North America, Europe, Asia Pacific | High | Near Term |
| Advancements in continuous glucose monitoring and Bluetooth-enabled smart devices | 1.80% | High | North America, Europe | High | Near Term |
| Expansion of telehealth and remote patient monitoring improving chronic care adoption | 1.50% | Moderate | North America, Asia Pacific | High | Near Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the blood glucose monitoring devices market with a 40.28% share in 2026, supported by advanced healthcare infrastructure, strong diabetes management practices, and broad access to sophisticated monitoring technologies. Healthcare providers and patients increasingly emphasize regular glucose monitoring as part of ongoing disease management, creating consistent demand for reliable and user-friendly devices. Established reimbursement and healthcare delivery systems, along with high awareness of diabetes care, further support device adoption. Continued interest in connected monitoring and technologies that enable patients to manage glucose levels more conveniently is also strengthening the regional market.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing region as diabetes awareness increases alongside improvements in healthcare access and diagnostic infrastructure. Expanding healthcare systems are enabling greater availability of glucose monitoring devices across hospitals, clinics, pharmacies, and home-care settings. Rising health awareness is encouraging patients to participate more actively in chronic disease management, while growing adoption of digital health technologies is creating demand for convenient and connected monitoring solutions. Broader access to healthcare services and increasing emphasis on preventive and long-term disease management are supporting strong regional expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Quality StandardsGermany emphasizes reliable blood glucose monitoring devices that comply with rigorous clinical and regulatory expectations. Healthcare institutions increasingly adopt accurate digital monitoring solutions that support long-term diabetes management and efficient patient follow-up.
France 🇫🇷
Preventive Care SupportFrance promotes blood glucose monitoring devices that contribute to preventive diabetes management and improved treatment adherence. Healthcare providers increasingly value reliable monitoring technologies that simplify patient engagement and facilitate consistent long-term disease management.
Italy 🇮🇹
Home Monitoring ExpansionItaly strengthens the adoption of blood glucose monitoring devices through greater emphasis on home-based diabetes care. Manufacturers are offering easy-to-use monitoring systems that improve accessibility while supporting healthcare professionals with dependable patient monitoring data.
Japan 🇯🇵
Aging Care SolutionsJapan advances blood glucose monitoring devices that address the growing need for convenient diabetes management among an aging population. Manufacturers prioritize compact designs, measurement accuracy, and user-friendly interfaces that support routine home-based monitoring.
South Korea 🇰🇷
Connected Health AdoptionSouth Korea encourages blood glucose monitoring devices with smartphone connectivity and digital health integration. Companies are improving device interoperability and mobile health applications to support personalized diabetes management across both clinical and home settings.
United States 🇺🇸
Digital Diabetes ManagementThe U.S. blood glucose monitoring devices market prioritizes connected monitoring systems that integrate with digital health platforms and remote patient management. Healthcare providers and device manufacturers continue enhancing data sharing, usability, and continuous monitoring capabilities for diabetes care.
Segment Leadership and Growth Trends
Blood Glucose Monitoring Devices Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Self-monitoring Devices (Largest Segment) vs Continuous Blood Glucose Monitoring Devices (Fastest-Growing Segment)
Self-monitoring devices dominated the blood glucose monitoring devices market, accounting for 64.02% share in 2026, supported by their established role in routine glucose assessment and diabetes self-management. Their accessibility, ease of use, and suitability for regular monitoring make them widely adopted by individuals who require convenient blood glucose checks outside clinical settings, while continued emphasis on effective disease management reinforces demand for these devices.
Continuous blood glucose monitoring devices represent the fastest-growing product segment as patients and healthcare providers increasingly favor technologies capable of providing ongoing glucose insights rather than relying solely on intermittent measurements. Their ability to support closer monitoring of glucose patterns, facilitate more informed treatment decisions, and improve patient engagement is strengthening adoption as diabetes care becomes increasingly focused on continuous and personalized management.
End-use Segment Analysis: Hospitals (Largest Segment) vs Home Care (Fastest-Growing Segment)
The hospitals segment held the largest share of the blood glucose monitoring devices market in 2026 at 43.57%, reflecting the essential role of glucose testing across diagnosis, treatment monitoring, inpatient care, and management of patients with varying clinical needs. Hospitals require dependable monitoring solutions across multiple departments and care settings, while the growing emphasis on timely glucose assessment supports sustained utilization within institutional healthcare environments.
Home care is the fastest-growing end-use segment as diabetes management increasingly shifts toward convenient monitoring outside traditional healthcare facilities. Greater patient involvement in disease management, demand for easier-to-use monitoring technologies, and the need for regular glucose assessment in everyday settings are encouraging broader adoption of devices designed for independent or caregiver-assisted use at home.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Self-monitoring Devices, Continuous Blood Glucose Monitoring Devices | Self-monitoring Devices | Continuous Blood Glucose Monitoring Devices |
| End-use | Hospitals, Home Care, Diagnostic Centers | Hospitals | Home Care |
Competitive Landscape and Market Positioning
Prominent players in the blood glucose monitoring devices market:
1. Abbott Laboratories (United States)
2. DexCom Inc. (United States)
3. Medtronic plc (Ireland)
4. F. Hoffmann-La Roche Ltd (Switzerland)
5. Senseonics Holdings Inc. (United States)
6. Insulet Corporation (United States)
7. i-SENS Inc. (South Korea)
8. Sinocare Inc. (China)
9. Ypsomed Holding AG (Switzerland)
10. AgaMatrix Inc. (United States)
The blood glucose monitoring devices market is advancing through increasing integration of digital health platforms and real-time monitoring capabilities. Device innovation is improving measurement accuracy and ease of use for long-term patient management. Continuous development in connected health ecosystems is enabling more personalized and data-driven diabetes care approaches.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories (United States) | |||||||
| DexCom Inc. (United States) | |||||||
| Medtronic plc (Ireland) | |||||||
| F. Hoffmann-La Roche Ltd (Switzerland) | |||||||
| Senseonics Holdings Inc. (United States) | |||||||
| Insulet Corporation (United States) | |||||||
| i-SENS Inc. (South Korea) | |||||||
| Sinocare Inc. (China) | |||||||
| Ypsomed Holding AG (Switzerland) | |||||||
| AgaMatrix Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| LifeScan | May-24 | LifeScan entered a strategic partnership with i-SENS to launch a new continuous glucose monitoring (CGM) platform. This move expands LifeScan’s existing diabetes management portfolio and enhances its competitive positioning within the rapidly growing global CGM sector by leveraging specialized sensing technology. |
| OSR Holdings | May-24 | OSR Holdings completed the acquisition of Woori IO, a South Korean developer specializing in non-invasive continuous glucose monitoring technology. This investment marks the company’s strategic entry into the CGM market, providing it with proprietary technology to compete in the shift toward less intrusive glucose management solutions. |
| Samsung Electronics | May-24 | Samsung Electronics is accelerating the development of non-invasive blood glucose monitoring technology for its Galaxy Watch and Galaxy Ring wearables. By integrating advanced health-tracking capabilities into consumer devices, the company aims to establish a foothold in the diabetes-related health monitoring segment and expand the functionality of its wearable ecosystem. |
| Samsung Electronics | May-24 | Samsung Electronics reported significant progress in integrating Advanced Glycation End-products (AGEs) monitoring into its wearable device portfolio. This development facilitates metabolic health assessment and risk screening, representing a strategic diversification of the company’s digital health offerings toward proactive diabetes management and early-stage metabolic risk monitoring. |
| Abbott Laboratories | Mar-23 | The FDA approved the integration of Abbott’s FreeStyle Libre 3 and FreeStyle Libre 2 sensors with automated insulin delivery (AID) systems. This regulatory milestone enables broader interoperability, allowing patients aged four and older to integrate their CGM data with insulin pumps for more precise, automated glycemic control. |
| Ascensia Diabetes Care | Feb-23 | Ascensia Diabetes Care formed a global partnership with SNAQ to integrate nutritional insights into its CONTOUR BGM system ecosystem. This collaboration enhances the patient experience by pairing accurate blood glucose data with meal-based analytics, supporting a more holistic approach to diabetes management. |
| Intuity Medical | Nov-21 | Intuity Medical launched the POGO Automatic blood glucose monitoring system in the U.S. market. The device features integrated test cartridges that simplify the monitoring process, representing a strategic effort to improve patient quality of life and adherence through a simplified, all-in-one testing solution. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Blood Glucose Monitoring Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Connectivity Capability | Non-Connected, Bluetooth-Enabled, Smartphone-Connected, Cloud-Connected |
| Patient Segment | Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Prediabetes & At-Risk Patients |
| Reimbursement Status | Fully Reimbursed, Partially Reimbursed, Privately Insured, Self-Pay |
Blood Glucose Monitoring Devices Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Diabetes Management Transformation Outlook |
|
| Remote Patient Monitoring Integration Analysis |
|
| Device Innovation Adoption Pathways |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of blood glucose monitoring devices?
How is the blood glucose monitoring devices industry size expected to evolve during the forecast period?
How are connected monitoring technologies reshaping demand in the blood glucose monitoring devices market?
Why is telehealth accelerating adoption of blood glucose monitoring devices?
Why do Self-monitoring Devices lead the blood glucose monitoring devices market?
Why is Home Care the fastest-growing end-use segment in the blood glucose monitoring devices market?
Why does North America lead the blood glucose monitoring devices market?
What is driving growth in the blood glucose monitoring devices market across Asia Pacific?
Which companies dominate the blood glucose monitoring devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization